About Nimoli Pharmaceuticals
Nimoli Pharmaceuticals was a Healthcare company based in Delhi (India) founded in 1998 by Vinod Kumar and Kulbhushan Bansal. Manufacturer of generic tablets, capsules, syrup, and injectables. It operates on a Traditional Pharmaceuticals model. The company has 22 employees. Its Indian entity Nimoli Pharmaceuticals (P) Ltd. reported revenue of ₹4.32 Cr. The company is recorded as dissolved. Nimoli Pharmaceuticals offers products and services including Nimoli Pharmaceuticals Platform. Its focus areas include Traditional Pharmaceuticals, Generics, Companies and Diversified.
Company details
Nimoli Pharmaceuticals offers Nimoli Pharmaceuticals Platform while focusing on providing healthcare solutions, traditional pharmaceuticals, traditional pharmaceuticals, and providing healthcare solutions. Manufacturer of generic tablets, capsules, syrup, and injectables. Delivering reliable solutions, it emphasizes quality, efficiency, and meeting diverse client needs.
- Headquarters Delhi, India
- Employees 22
- Founders Vinod Kumar, Kulbhushan Bansal
- SectorsHealthcare
- Website nimolipharma.com
- Legal Name Nimoli Pharmaceuticals (P) Ltd.
- Date of Incorporation 04 Aug, 1998
- Jurisdiction New Delhi, Delhi, India
- Annual Revenue₹4.32 Cr
FY 2022 · +12% YoY
- Net Profit₹3.3 Lakh
FY 2022
- EBITDA₹10.4 Lakh
FY 2022 · 2% margin
- Employee Count22
Associated legal entities of Nimoli Pharmaceuticals
Nimoli Pharmaceuticals operates through Nimoli Pharmaceuticals (P) Ltd. (active). Its filings, financials, charges and directors are on the company page.
| Legal entity | Status | Incorporated | Registered in | Revenue (FY 2022) | Employees | Directors | Company page |
|---|---|---|---|---|---|---|---|
| Nimoli Pharmaceuticals (P) Ltd. CIN U24232DL1998PTC361925 | Active | 04 Aug 1998 | New Delhi, Delhi | ₹4.3 Cr | 22 | 3 | View details |
Products & Services of Nimoli Pharmaceuticals
Nimoli Pharmaceuticals offers a comprehensive portfolio of products and services, including Nimoli Pharmaceuticals Platform.
Manufacturer of generic tablets, capsules, syrup, and injectables
Board of directors of Nimoli Pharmaceuticals (P) Ltd. (Nimoli Pharmaceuticals)
Nimoli Pharmaceuticals (P) Ltd. is the primary company behind Nimoli Pharmaceuticals. The board of Nimoli Pharmaceuticals (P) Ltd. currently have 3 directors; the longest-serving is Vinod Kumar Sharma, appointed in 1998. 1 earlier director has ceased.
| Director | Designation | Appointed | Tenure | Entity |
|---|---|---|---|---|
| Vinod Kumar Sharma DIN 01869419 | Director | 04 Aug 1998 | 28 yrs 2 mo | Nimoli Pharmaceuticals (P) Ltd. |
| Vimla Sharma DIN 01869412 | Director | 16 Aug 2005 | 21 yrs 2 mo | Nimoli Pharmaceuticals (P) Ltd. |
| Sudesh Bansal DIN 02344246 | Director | 16 Aug 2005 | 21 yrs 2 mo | Nimoli Pharmaceuticals (P) Ltd. |
People of Nimoli Pharmaceuticals
2 people are tracked at Nimoli Pharmaceuticals (2 in leadership); the tracked headcount is 22.
| Name | Role | Group |
|---|---|---|
| Co-Founder | Leadership | |
| Co-Founder | Leadership |
Complete people profiles for Nimoli Pharmaceuticals
Full employee and board profiles, team structure, tenure and professional contact details require an active premium plan.
- Full employee list
- Team structure
- Board tenure
- Professional contacts
Verified entity values are shown only after access is granted.
Financials of Nimoli Pharmaceuticals
Figures of Nimoli Pharmaceuticals (P) Ltd., the primary company behind Nimoli Pharmaceuticals, for FY 2022. Revenue was ₹4.32 Cr (+12% year on year). Net profit was ₹3.3 Lakh. EBITDA was ₹10.4 Lakh (2% margin). Revenue has grown at a compounded annual rate of 0% over three years and -3% over five years.
- ₹4.32 CrRevenue · FY 2022 · +12% YoY
- ₹3.3 LakhNet profit
- ₹10.4 LakhEBITDA · 2% margin
- 22Employees (provident fund records)
- 0%Revenue CAGR, 3 years
- -3%Revenue CAGR, 5 years
Balance sheet, profit and loss, cash flow and ratios of Nimoli Pharmaceuticals (P) Ltd. are on its company page.
Detailed financial statements for Nimoli Pharmaceuticals
Statement rows, ratios, five-year trends and downloadable financials of the group companies require an active premium plan.
- Statement rows
- Financial ratios
- Five-year trends
- Downloads
Verified entity values are shown only after access is granted.
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Frequently Asked Questions about Nimoli Pharmaceuticals
Nimoli Pharmaceuticals was founded in 1998.
Nimoli Pharmaceuticals is headquartered in Delhi, India. It is registered at Delhi, Delhi, India.
Nimoli Pharmaceuticals has 22 employees.
The primary company behind Nimoli Pharmaceuticals, Nimoli Pharmaceuticals (P) Ltd., reported revenue of ₹4.32 Cr for FY 2022, up 12% year on year.
Nimoli Pharmaceuticals offers Nimoli Pharmaceuticals Platform while focusing on providing healthcare solutions, traditional pharmaceuticals, traditional pharmaceuticals, and providing healthcare solutions. Manufacturer of generic tablets, capsules, syrup, and injectables. Delivering reliable solutions, it emphasizes quality, efficiency, and meeting diverse client needs.
Nimoli Pharmaceuticals offers Nimoli Pharmaceuticals Platform.
Nimoli Pharmaceuticals operates through Nimoli Pharmaceuticals (P) Ltd..
The legal entities of Nimoli Pharmaceuticals currently have 3 directors, including Vimla Sharma, Vinod Kumar Sharma, Sudesh Bansal.